Details for Patent: 8,246,978

✉ Email this page to a colleague

Which drugs does patent 8,246,978 protect, and when does it expire?

Patent 8,246,978 protects TWIRLA and is included in one NDA.

This patent has nineteen patent family members in twelve countries.

Summary for Patent: 8,246,978

Title:	Dermal delivery device with reduced loss of its volatile components
Abstract:	This invention relates to a transdermal drug delivery device that comprises an active ingredient (AI) layer, having a skin contacting surface and a non-skin contacting surface and comprising a volatile component, a release liner impermeable to the volatile component adjacent the skin contacting surface of the AI layer having a perimeter that extends beyond the perimeter of the AI layer in all directions, and an overlay comprising a pressure sensitive adhesive (PSA) that does not absorb the volatile component adjacent the non-skin contacting surface of the AI layer having a perimeter of which extends beyond the perimeter of the AI layer in all directions, wherein the release liner and the PSA of the overlay are in contact with and adhered to each other around the perimeter of the AI layer to form a seal that reduces or prevents volatile component loss.
Inventor(s):	Kydonieus; Agis (Princeton, NJ), Conway; Robert G. (Princeton, NJ), Rossi; Thomas M. (Princeton, NJ)
Assignee:	Agile Therapeutics, Inc. (Princeton, NJ)
Application Number:	12/668,322
Patent Claim Types: see list of patent claims	Use; Compound; Delivery; Device;

Drugs Protected by US Patent 8,246,978

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Agile	TWIRLA	ethinyl estradiol; levonorgestrel	SYSTEM;TRANSDERMAL	204017-001	Feb 14, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 8,246,978

PCT Information
PCT Filed	July 10, 2008	PCT Application Number:	PCT/US2008/069618
PCT Publication Date:	January 15, 2009	PCT Publication Number:	WO2009/009649

International Family Members for US Patent 8,246,978

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2008275101	⤷ Sign Up
Brazil	PI0814697	⤷ Sign Up
Canada	2692884	⤷ Sign Up
China	101801321	⤷ Sign Up
Eurasian Patent Organization	020208	⤷ Sign Up
Eurasian Patent Organization	201070123	⤷ Sign Up
European Patent Office	2167001	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.